Shining a spotlight on race & ethnicity in systemic AL amyloidosis
With an increasingly more diverse profile of patients diagnosed with AL amyloidosis, there is a need to better understand how this unique disease may affect various patient groups differently.
Author
Andrew Staron
Hematology & Oncology Clinical Fellow, Boston University Medical Center
Contributing author
Vaishali Sanchorawala
MD, Boston University School of Medicine